Emerging considerations in the reversal of neuromuscular blockade and residual block

Wayne T. Nicholson, Juraj Sprung, Christopher J. Jankowski

Research output: Contribution to journalArticle

Abstract

Incomplete recovery following reversal of neuromuscular blockade can present as a clinical problem in surgical patients. Emerging pharmacologic solutions may prevent such adverse outcomes in the future. We briefly review two methods of pharmacologic reversal of neuromuscular blockade. Both methods of reversal are effective. However the early studies of the new compound, sugammadex has been shown to achieve a more rapid, stable reversal of steroidal based neuromuscular blocking agents compared to neostigmine. Due to the novel mechanism of action of this agent, sugammadex has been demonstrated to be effective even when administered during profound neuromuscular block, without evidence of recurarization.

Original languageEnglish (US)
Pages (from-to)35-38
Number of pages4
JournalSigna Vitae
Volume3
Issue number1
StatePublished - 2008

Fingerprint

Delayed Emergence from Anesthesia
Neuromuscular Blockade
Neuromuscular Blocking Agents
Neostigmine
Sugammadex

Keywords

  • Cholinesterase inhibitor
  • Cyclodextrin
  • Org 25969
  • Rocuronium
  • Sugammadex

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine

Cite this

Nicholson, W. T., Sprung, J., & Jankowski, C. J. (2008). Emerging considerations in the reversal of neuromuscular blockade and residual block. Signa Vitae, 3(1), 35-38.

Emerging considerations in the reversal of neuromuscular blockade and residual block. / Nicholson, Wayne T.; Sprung, Juraj; Jankowski, Christopher J.

In: Signa Vitae, Vol. 3, No. 1, 2008, p. 35-38.

Research output: Contribution to journalArticle

Nicholson, WT, Sprung, J & Jankowski, CJ 2008, 'Emerging considerations in the reversal of neuromuscular blockade and residual block', Signa Vitae, vol. 3, no. 1, pp. 35-38.
Nicholson, Wayne T. ; Sprung, Juraj ; Jankowski, Christopher J. / Emerging considerations in the reversal of neuromuscular blockade and residual block. In: Signa Vitae. 2008 ; Vol. 3, No. 1. pp. 35-38.
@article{a7a5770921df49c4ae1e4a8b4f7c2555,
title = "Emerging considerations in the reversal of neuromuscular blockade and residual block",
abstract = "Incomplete recovery following reversal of neuromuscular blockade can present as a clinical problem in surgical patients. Emerging pharmacologic solutions may prevent such adverse outcomes in the future. We briefly review two methods of pharmacologic reversal of neuromuscular blockade. Both methods of reversal are effective. However the early studies of the new compound, sugammadex has been shown to achieve a more rapid, stable reversal of steroidal based neuromuscular blocking agents compared to neostigmine. Due to the novel mechanism of action of this agent, sugammadex has been demonstrated to be effective even when administered during profound neuromuscular block, without evidence of recurarization.",
keywords = "Cholinesterase inhibitor, Cyclodextrin, Org 25969, Rocuronium, Sugammadex",
author = "Nicholson, {Wayne T.} and Juraj Sprung and Jankowski, {Christopher J.}",
year = "2008",
language = "English (US)",
volume = "3",
pages = "35--38",
journal = "Signa Vitae",
issn = "1334-5605",
publisher = "Pharmamed Mado Ltd.",
number = "1",

}

TY - JOUR

T1 - Emerging considerations in the reversal of neuromuscular blockade and residual block

AU - Nicholson, Wayne T.

AU - Sprung, Juraj

AU - Jankowski, Christopher J.

PY - 2008

Y1 - 2008

N2 - Incomplete recovery following reversal of neuromuscular blockade can present as a clinical problem in surgical patients. Emerging pharmacologic solutions may prevent such adverse outcomes in the future. We briefly review two methods of pharmacologic reversal of neuromuscular blockade. Both methods of reversal are effective. However the early studies of the new compound, sugammadex has been shown to achieve a more rapid, stable reversal of steroidal based neuromuscular blocking agents compared to neostigmine. Due to the novel mechanism of action of this agent, sugammadex has been demonstrated to be effective even when administered during profound neuromuscular block, without evidence of recurarization.

AB - Incomplete recovery following reversal of neuromuscular blockade can present as a clinical problem in surgical patients. Emerging pharmacologic solutions may prevent such adverse outcomes in the future. We briefly review two methods of pharmacologic reversal of neuromuscular blockade. Both methods of reversal are effective. However the early studies of the new compound, sugammadex has been shown to achieve a more rapid, stable reversal of steroidal based neuromuscular blocking agents compared to neostigmine. Due to the novel mechanism of action of this agent, sugammadex has been demonstrated to be effective even when administered during profound neuromuscular block, without evidence of recurarization.

KW - Cholinesterase inhibitor

KW - Cyclodextrin

KW - Org 25969

KW - Rocuronium

KW - Sugammadex

UR - http://www.scopus.com/inward/record.url?scp=77953664020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953664020&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77953664020

VL - 3

SP - 35

EP - 38

JO - Signa Vitae

JF - Signa Vitae

SN - 1334-5605

IS - 1

ER -